Search results
Why We Think Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Compensation Is Not Excessive At All
Simply Wall St. via Yahoo Finance· 1 year agoThe performance at Xenetic Biosciences, Inc. (NASDAQ:XBIO) has been rather lacklustre of late and...
Xenetic Biosciences (NASDAQ:XBIO) Is In A Good Position To Deliver On Growth Plans
Simply Wall St. via Yahoo Finance· 12 months agoEven when a business is losing money, it's possible for shareholders to make money if they buy a...
This Is Why Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Compensation Looks Appropriate
Simply Wall St. via Yahoo Finance· 1 year agoThe performance at Xenetic Biosciences, Inc. (NASDAQ:XBIO) has been rather lacklustre of late and...
Xenetic Biosciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
Simply Wall St. via Yahoo Finance· 1 month agoXenetic Biosciences (NASDAQ:XBIO) Full Year 2023 Results Key Financial Results Revenue: US$2.54m (up...
Most Shareholders Will Probably Agree With Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO...
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights Xenetic Biosciences will host its Annual General Meeting on 6th of December Total pay...